PKPD-NN_DMT
Indication: Clinical DMT dose exploration in healthy adults
Interactive population PK/PD simulator for intravenous DMT with plasma DMT, IAA metabolite, effect-site equilibration, and predicted psychedelic intensity based on Eckernas et al. 2022.
Drug Overview
Clinical Context
- Molecular Target
- Psychedelic intensity
- Drug Class
- Serotonergic psychedelic
- Therapeutic Area
- Psychiatry
- Indication
- Clinical DMT dose exploration in healthy adults
- Route of Administration
- Intravenous bolus
Model Information
- Model Type
- Population PK/PD (2-compartment IV bolus plus effect-site sigmoid Emax)
This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.
About This Simulator
This interactive pharmacokinetic simulator for PKPD-NN_DMT allows you to explore concentration-time profiles under different dosing scenarios. The underlying Population PK/PD (2-compartment IV bolus plus effect-site sigmoid Emax) model characterizes the pharmacokinetics of this serotonergic psychedelic following intravenous bolus administration.
Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration). The pharmacodynamic component links drug exposure to therapeutic or safety endpoints.
Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.
Frequently Asked Questions
What is the PKPD-NN_DMT PK simulator?
This is a free, interactive pharmacokinetic simulator for PKPD-NN_DMT used in Clinical DMT dose exploration in healthy adults. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.
What drug class does PKPD-NN_DMT belong to?
PKPD-NN_DMT is classified as a Serotonergic psychedelic that targets Psychedelic intensity. It is used in the Psychiatry therapeutic area.
What route of administration does this model simulate?
This simulator models Intravenous bolus administration of PKPD-NN_DMT. The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.
What type of PK model is used?
This simulator uses a Population PK/PD (2-compartment IV bolus plus effect-site sigmoid Emax) model. PK/PD models link drug concentrations to pharmacological effects, allowing exploration of exposure-response relationships.
Is this simulator free to use?
Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.
Can I use this for clinical dosing decisions?
No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.
Related Simulators
Ready to Simulate?
Launch the PKPD-NN_DMT simulator to explore dosing scenarios and pharmacokinetic profiles interactively.
🚀 Launch SimulatorComments
⚠️ Disclaimer
This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.
Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community